World's Best Scientists 2026 revealed!
Nasser K. Altorki

Nasser K. Altorki

D-Index & Metrics

Medicine

D-Index
104
Citations
47375
World Ranking
6976
National Ranking
3670

Overview

Nasser K. Altorki is affiliated with Cornell University in the United States and has a significant body of work within the field of Medicine, focusing primarily on Pulmonary and Respiratory Medicine, Oncology, and Surgery, with additional contributions to Molecular Biology and Radiology, Nuclear Medicine and Imaging.

Their research extensively covers topics related to Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, as well as Esophageal Cancer Research and Treatment. Further areas of interest include Radiomics and Machine Learning in Medical Imaging, Cancer Genomics and Diagnostics, and Gastric Cancer Management and Outcomes.

Frequent co-authors include:

  • Jeffrey L. Port
  • Olivier Elemento
  • Jonathan Villena-Vargas
  • Timothy E. McGraw
  • S. Harrison

Altorki's work is published predominantly in key venues such as:

  • Journal of Thoracic and Cardiovascular Surgery
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Thoracic Oncology
  • Cancer Research
  • Journal of Clinical Oncology

Notable recent publications include:

  • "Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer," 2023, New England Journal of Medicine
  • "Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial," 2021, The Lancet Oncology

Other papers associated with Altorki's co-authors reflect the broader research environment they are part of, including work published in The Lancet, Nature Medicine, and Annals of Oncology on topics such as adjuvant therapies and cancer monitoring.

Best Publications

  • VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

    Rosandra N. Kaplan;Rebecca D. Riba;Stergios Zacharoulis;Anna H. Bramley

  • Early Lung Cancer Action Project: overall design and findings from baseline screening

    Claudia I Henschke;Dorothy I McCauley;David F Yankelevitz;David P Naidich

  • Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

    Kari R. Fischer;Anna Durrans;Sharrell Lee;Jianting Sheng

  • TOX is a critical regulator of tumour-specific T cell differentiation

    Andrew C Scott;Andrew C Scott;Friederike Dündar;Paul Zumbo;Smita S Chandran

  • Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial.

    Enriqueta Felip;Nasser Altorki;Caicun Zhou;Tibor Csőszi

  • The lung microenvironment: an important regulator of tumour growth and metastasis

    Nasser K. Altorki;Geoffrey J. Markowitz;Dingcheng Gao;Jeffrey L. Port

  • Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: A propensity-matched analysis from the STS database

    Subroto Paul;Nasser K. Altorki;Shubin Sheng;Paul C. Lee

  • Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.

    Andrew J Dannenberg;Nasser K Altorki;Jay O Boyle;Chau Dang

  • Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: Correlation with antibody responses

    Sacha Gnjatic;Djordje Atanackovic;Elke Jäger;Mitsutoshi Matsuo

  • Immunohistochemical analysis of NY‐ESO‐1 antigen expression in normal and malignant human tissues

    Achim A. Jungbluth;Yao-Tseng Chen;Elisabeth Stockert;Klaus J. Busam

  • Early lung cancer action project: initial findings on repeat screenings.

    Claudia I. Henschke;David P. Naidich;David F. Yankelevitz;Georgeann McGuinness

  • The Number of Lymph Nodes Removed Predicts Survival in Esophageal Cancer: An International Study on the Impact of Extent of Surgical Resection

    Christian G Peyre;Jeffrey A Hagen;Steven R DeMeester;Nasser K Altorki

  • Three-Field Lymph Node Dissection for Squamous Cell and Adenocarcinoma of the Esophagus

    Nasser Altorki;Michael Kent;Cathy Ferrara;Jeffrey Port

  • Inhibition of cyclooxygenase-2 gene expression by p53.

    Kotha Subbaramaiah;Nasser Altorki;Wen Jing Chung;Juan R. Mestre

  • Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial

    Johan F. Vansteenkiste;Byoung Chul Cho;Tonu Vanakesa;Tommaso De Pas

  • MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival

    Ewy A. Mathé;Giang Huong Nguyen;Elise D. Bowman;Yiqiang Zhao;Yiqiang Zhao

  • Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non–Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial

    Karen Kelly;Nasser K. Altorki;Wilfried E.E. Eberhardt;Mary E.R. OBrien

  • Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer

    Ali O. Gure;Ramon Chua;Barbara Williamson;Mithat Gonen

  • TGF-β IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer

    Zhan Yao;Silvia Fenoglio;Ding Cheng Gao;Matthew Camiolo

  • Prediction of lung cancer using volatile biomarkers in breath.

    Michael Phillips;Nasser Altorki;John H.M. Austin;Robert B. Cameron

Frequent Co-Authors

Vivek Mittal
Vivek Mittal Cornell University
David F. Yankelevitz
David F. Yankelevitz Icahn School of Medicine at Mount Sinai
Andrew J. Dannenberg
Andrew J. Dannenberg Cornell University
Claudia I. Henschke
Claudia I. Henschke Cornell University
Lloyd J. Old
Lloyd J. Old Ludwig Cancer Research
Kotha Subbaramaiah
Kotha Subbaramaiah Cornell University
Yao-Tseng Chen
Yao-Tseng Chen Cornell University
Sacha Gnjatic
Sacha Gnjatic Icahn School of Medicine at Mount Sinai
Timothy E. McGraw
Timothy E. McGraw Cornell University
Paul J. Christos
Paul J. Christos Cornell University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens many doors to related online programs and career opportunities. For those interested in the business and organizational side of healthcare, a healthcare administration degree can prepare you for management roles in diverse medical settings. Many programs now offer flexible online learning options, ideal for those balancing work and study.

Registered nurses who aspire to advanced practice can accelerate their careers with rn to np bridge programs. These programs enable RNs to become nurse practitioners, often in less time than traditional routes.

Nutrition is another growing field within healthcare. An online nutrition degree prepares students for roles in dietetics, wellness coaching, and health education, while offering the convenience of remote study.

For aspiring healthcare leaders, choosing the right program is essential. Find out which online healthcare administration programs have cahme accreditation? to ensure your degree meets rigorous industry standards and boosts your career prospects.

Best Scientists Citing Nasser K. Altorki

Trending Scientists